Organogenesis Holdings (ORGO) Equity Ratio (2015 - 2026)

Organogenesis Holdings' Equity Ratio history runs 12 years deep, the most recent figure standing at 0.47 for Q1 2026.

• In Q1 2026, Equity Ratio fell 9.5% year-over-year to 0.47; the TTM figure through Mar 2026 stood at 0.47 (down 9.5% YoY), while the FY2025 annual figure was 0.5, down 5.07% from the prior year.
• Equity Ratio was 0.47 for Q1 2026 at Organogenesis Holdings, down from 0.5 in the prior quarter.
• In the past five years, Equity Ratio ranged from a high of 0.62 in Q3 2024 to a low of 0.47 in Q1 2026.
• Historically, Equity Ratio has averaged 0.56 across 5 years, with a median of 0.56 in 2022.
• The sharpest annual moves came in 2022 and 2025: Equity Ratio grew 15.48% in 2022, then fell 19.82% in 2025.
• A 5-year view of Equity Ratio shows it stood at 0.59 in 2022, then rose by 2.46% to 0.61 in 2023, then decreased by 12.83% to 0.53 in 2024, then decreased by 5.07% to 0.5 in 2025, then slipped by 6.18% to 0.47 in 2026.
• The last three Equity Ratio figures came in at 0.47 (Q1 2026), 0.5 (Q4 2025), and 0.5 (Q3 2025), per Business Quant data.